Latest Biotechnology Clinical Trials News

Page 1 of 1

Prescient Therapeutics Launches $7M Share Purchase Plan to Accelerate PTX-100 Trials

Prescient Therapeutics has opened a Share Purchase Plan to raise up to $7 million, offering shareholders discounted shares to fund the Phase 2 development of its targeted cancer therapy PTX-100.

Ada Torres

2 July 2025

Top